Tradestie Institutional Equity Comparison Engine
NMAD vs ENSC โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ENSC Overall Edge
ENSC Captures Institutional Edge (3โ0 Pillars ยท 9โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ensysce Biosciences, Inc. Common Stock (ENSC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, NMAD trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ENSC at 0.8x Forward P/E and -281.3% operating margin (-15.1% YoY). In options structure, NMAD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ENSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ENSC
NMAD N/M vs ENSC 0.8x Fwd P/E
Growth & Margin Winner
ENSC
Op Margin N/A vs -281.3% ยท YoY N/A vs -15.1%
Momentum & Technical Winner
ENSC
1Y -65.1% vs -80.3% ยท 52W Pos 8% vs 8%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
NMAD
US Equity
NMAD
Institutional Equity
$2.56
+13.53% 1D
Market Cap
N/A
1M Return
-28.89%
1Y Return
-65.12%
Forward P/E
N/M
Unified AI Score
47.9 / 100
HOLD
Tech 43.0
Fund 49.0
Flow 50.0
Mom 70.0
ENSC
NASDAQ
Ensysce Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$0.36
-0.17% 1D
Market Cap
$7.0M
1M Return
-29.55%
1Y Return
-80.33%
Forward P/E
0.8x
Unified AI Score
53.4 / 100
HOLD
Tech 50.0
Fund 62.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NMAD -65.12%
ENSC -80.33%
Spread: +87.24 pp (ENSC Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NMAD TTM Op. Margin: N/A
ENSC TTM Op. Margin: -281.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NMAD vs ENSC. Trailing 12-month operating profitability (NMAD N/A vs ENSC -281.3%) and valuation multiples (NMAD N/M vs ENSC 0.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMAD | ENSC | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $7.0M | Larger Scale | ENSC |
| Trailing P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Forward P/E Ratio Valuation | N/M | 0.8x | Lower Multiple | ENSC |
| Revenue Growth (YoY) Growth | N/A | -15.1% | Higher Growth | ENSC |
| Operating Margin (TTM) Profitability | N/A | -281.3% | Higher Margin | ENSC |
| Net Profit Margin Profitability | N/A | -280.5% | Higher Margin | ENSC |
| Return on Equity (ROE) Capital Efficiency | N/A | -1295.1% | Higher ROE | ENSC |
| 52-Week Range Position Momentum | 8% ($2โ$8) | 8% ($0โ$2) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 0.52ฮฒ ยท 173% Vol | 0.98ฮฒ ยท 79% Vol | Lower Realized Risk | ENSC |
| Unified Institutional Score Composite Signal | 47.9 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | ENSC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NMAD vs ENSC Buy Guide
NMAD
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ENSC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NMAD nor ENSC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.